- Home
- CPAC vs PRTA Comparison
CPAC vs PRTA Comparison
Compare CPAC & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- PRTA
- Stock Information
- Founded
- CPAC 1949
- PRTA 2012
- Country
- CPAC Peru
- PRTA Ireland
- Employees
- CPAC N/A
- PRTA N/A
- Industry
- CPAC Building Materials
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- PRTA Health Care
- Exchange
- CPAC Nasdaq
- PRTA Nasdaq
- Market Cap
- CPAC 580.5M
- PRTA 472.1M
- IPO Year
- CPAC 2012
- PRTA N/A
- Fundamental
- Price
- CPAC $7.10
- PRTA $8.06
- Analyst Decision
- CPAC Hold
- PRTA Buy
- Analyst Count
- CPAC 1
- PRTA 10
- Target Price
- CPAC $6.40
- PRTA $12.29
- AVG Volume (30 Days)
- CPAC 5.5K
- PRTA 869.0K
- Earning Date
- CPAC 10-27-2025
- PRTA 11-11-2025
- Dividend Yield
- CPAC 7.08%
- PRTA N/A
- EPS Growth
- CPAC 26.68
- PRTA N/A
- EPS
- CPAC 0.14
- PRTA N/A
- Revenue
- CPAC $572,828,408.00
- PRTA $10,341,000.00
- Revenue This Year
- CPAC N/A
- PRTA N/A
- Revenue Next Year
- CPAC N/A
- PRTA $602.32
- P/E Ratio
- CPAC $9.67
- PRTA N/A
- Revenue Growth
- CPAC 3.37
- PRTA N/A
- 52 Week Low
- CPAC $5.10
- PRTA $4.32
- 52 Week High
- CPAC $7.32
- PRTA $22.41
- Technical
- Relative Strength Index (RSI)
- CPAC 67.55
- PRTA 49.02
- Support Level
- CPAC $6.50
- PRTA $8.10
- Resistance Level
- CPAC $6.97
- PRTA $8.50
- Average True Range (ATR)
- CPAC 0.24
- PRTA 0.33
- MACD
- CPAC 0.03
- PRTA -0.10
- Stochastic Oscillator
- CPAC 79.25
- PRTA 3.45
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.